N/A
Completed N=25
Virtual Reality to Promote Relaxation Prior to Simulation
Source: ClinicalTrials.gov NCT06318338 ↗Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcomePrimary: Feasibility of a Pre-simulation VR Platform Prior to Radiation — 25 Participants
Summary
The purpose of this study is to assess the feasibility of a pre-simulation virtual reality (VR) platform designed to promote relaxation for cancer patients planned for radiation therapy (RT).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of a Pre-simulation VR Platform Prior to Radiation |
25 | — |
| SECONDARY Patient Situational Anxiety Prior to and After Use of VR Program (HADS) |
11.1; 9.0 | — |
| SECONDARY Patient Situational Anxiety Prior to and After Use of VR Program (STAI-6) |
43.3; 29.3 | — |
Eligibility Criteria
Inclusion Criteria
- Able to understand, read or speak English sufficient for signing of informed consent and completion of study assessments
- Patients scheduled for simulation for radiation treatment planning at Perelman Center for Advanced Medicine (PCAM)
- Adults, at least 18 years of age
- Performance Status (ECOG) 0-2
Exclusion Criteria
- Prior radiotherapy
- History of motion sickness, car sickness, vertigo, migraines, or light sensitivity within the last 6 months
- History of epilepsy and seizures
- Current nausea, vomiting, dizziness, lightheadedness, monocular vision or hearing loss that is not treated
Data sourced from ClinicalTrials.gov (NCT06318338). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.